KCT0001179已完成未知
A Phase I, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous CT-P27 in Healthy Subjects.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Celltrion
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 18(Year) 至 55(Year)（—）
- 性别
- All
入选标准
- •1. Subject is healthy male or female, and between 18 and 55 years old (both inclusive).
- •2. Subject's body mass index (BMI) is of =30.0 kg/m2 and weight is of =50.0 kg.
排除标准
- •1. Subject has a medical condition of disease including endocrine, cardiovascular, infection, cancer, or renal, neurological, hemotologic disease.
- •2. History or presence of regular alcohol consumption
- •3. Subject in pregnancy or breastfeeding
- •4. Veins unsuitable for infusion and/or repeat venipuncture
- •5. Vulnerable subjects
研究者
相似试验
已完成
1 期
A Phase I, Randomised, Double-Blind, Placebo-Controlled,AscendingSingle- and Repeat-Dose Study of the Safety,Tolerability andPharmacokinetics of Orally Administered PRN473.ACTRN12613000951752Clinical Network Services114
进行中（未招募）
1 期
The second healthy volunteer study assessing the safety, tolerability, and pharmacokinetics (blood levels) of gerilimzumab against placebo.Rheumatoid ArthritisACTRN12615001141538Clinical Network Services Pty Ltd18
已完成
1 期
A First in Human study assessing the safety, tolerability and pharmacokinetics (blood levels) of gerilimzumab against placebo.Rheumatoid ArthritisACTRN12615000891527Clinical Network Services Pty Ltd32
已完成
1 期
A Phase 1, Randomised, Double-Blind, Placebo-Controlled, First in Human Study of the Safety, Tolerability and Pharmacokinetics of AI-071 in Healthy Volunteers.COVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12622000643774AcroImmune Australia Biotech Pty Ltd40
已完成
1 期
A Phase 1, Randomised, Double-Blind, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability and Pharmacokinetics of AXN-001 in Healthy Volunteers.Neurological - Other neurological disordersMigraineACTRN12623000296639Avance Clinical Pty Ltd36